Skip header and navigation

Narrow By

56 records – page 2 of 3.

Hyperbaric oxygen therapy

https://libcat.nshealth.ca/en/permalink/chpams37622
Nova Scotia Health Authority. QEII. Hyperbaric Medicine Unit. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2309
Available Online
View Pamphlet
Hyperbaric oxygen therapy is used to treat decompression sickness in divers, severe (very bad) carbon monoxide poisoning, and wounds related to diabetes, vascular disease, and radiation injury. This pamphlet explains what hyperbaric oxygen therapy is, where to go for appointments, how it is done, how often treatment are done, and when to expect your appointment schedule. Other topics include: possible risks and complications, smoking, taking medications, feeling sick, and support persons. A lin…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Hyperbaric Medicine Unit
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Hyperbaric Oxygenation
Subjects (LCSH)
Hyperbaric oxygenation
Specialty
Respiratory System
Abstract
Hyperbaric oxygen therapy is used to treat decompression sickness in divers, severe (very bad) carbon monoxide poisoning, and wounds related to diabetes, vascular disease, and radiation injury. This pamphlet explains what hyperbaric oxygen therapy is, where to go for appointments, how it is done, how often treatment are done, and when to expect your appointment schedule. Other topics include: possible risks and complications, smoking, taking medications, feeling sick, and support persons. A link to a video is also given.
Responsibility
Prepared by: Hyperbaric Medicine Unit, QEII
Pamphlet Number
2309
Less detail

Implanted vascular access device (IVAD or "port")

https://libcat.nshealth.ca/en/permalink/chpams36613
Nova Scotia Health Authority. QEII. Minor Procedures, Nova Scotia Health Authority. Hants Community Hospital. Same Day Surgery Unit, Nova Scotia Health Authority. Yarmouth Regional Hospital. Oncology Unit. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0421
Available Online
View Pamphlet
An implanted vascular access device (IVAD) is a small device that goes into a large vein just above your heart. This makes it easier to give you intravenous (IV) medications and to take blood samples. It is also called a “port” or “port-a-cath.” A port is placed under your skin below your collarbone. Topics include: benefits, how it works, how to get ready for surgery, what to expect during and after surgery, care at home, and taking care of your port. A space to write your doctor's name and ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Minor Procedures
Nova Scotia Health Authority. Hants Community Hospital. Same Day Surgery Unit
Nova Scotia Health Authority. Yarmouth Regional Hospital. Oncology Unit
Alternate Title
Port
Port-a-cath
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Vascular Access Device
Neoplasms - therapy
Subjects (LCSH)
Drug infusion pumps
Cancer--Treatment
Abstract
An implanted vascular access device (IVAD) is a small device that goes into a large vein just above your heart. This makes it easier to give you intravenous (IV) medications and to take blood samples. It is also called a “port” or “port-a-cath.” A port is placed under your skin below your collarbone. Topics include: benefits, how it works, how to get ready for surgery, what to expect during and after surgery, care at home, and taking care of your port. A space to write your doctor's name and phone number is given in case you have any problems.
Notes
Previous title: Implanted infusion port
Responsibility
Prepared by: Minor Procedures, QEII; SDSU, Hants Community Hospital; Oncology Unit, Yarmouth Regional Hospital
Pamphlet Number
0421
Less detail

Initiation and motivation after an acquired brain injury (ABI)

https://libcat.nshealth.ca/en/permalink/chpams37479
Nova Scotia Health Authority. Acquired Brain Injury Ambulatory Care Teams. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2228
Available Online
View Pamphlet
Initiation is the ability to start an activity. Motivation is the desire to do an activity. Many people with an acquired brain injury (ABI) have trouble doing tasks or taking part in activities. This is often caused by a problem with initiation, not because you are not motivated. This pamphlet explains how problems with initiation may affect you and what you can do to help with initiation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Acquired Brain Injury Ambulatory Care Teams
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Motivation
Brain Injuries - psychology
Subjects (LCSH)
Motivation (Psychology)
Brain--Wounds and injuries--Complications
Specialty
Nervous System
Abstract
Initiation is the ability to start an activity. Motivation is the desire to do an activity. Many people with an acquired brain injury (ABI) have trouble doing tasks or taking part in activities. This is often caused by a problem with initiation, not because you are not motivated. This pamphlet explains how problems with initiation may affect you and what you can do to help with initiation.
Responsibility
Prepared by: Acquired Brain Injury Ambulatory Care Teams
Pamphlet Number
2228
Less detail

Intensive Care Unit : Valley Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams38213
Nova Scotia Health Authority. Valley Regional Hospital. ICU Pracitce Committee. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2363
Available Online
View Pamphlet
This pamphlet gives important information for support persons visiting patients in the Intensive Care Unit (ICU). The pamphlet gives information about a family spokesperson, visiting the ICU, infection risks, the health care team, what to expect in the ICU, keeping patients safe and comfortable, the family waiting room, and leaving the ICU. Information about taking care of yourself and a list of frequently asked questions is also included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Valley Regional Hospital. ICU Pracitce Committee
Alternate Title
ICU : VRH
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (18 p.) : digital, PDF file
Subjects (MeSH)
Intensive Care Units
Subjects (LCSH)
Intensive care units
Specialty
Intensive Care Unit
Abstract
This pamphlet gives important information for support persons visiting patients in the Intensive Care Unit (ICU). The pamphlet gives information about a family spokesperson, visiting the ICU, infection risks, the health care team, what to expect in the ICU, keeping patients safe and comfortable, the family waiting room, and leaving the ICU. Information about taking care of yourself and a list of frequently asked questions is also included.
Responsibility
Prepared by: ICU Practice Committee, VRH
Pamphlet Number
2363
Less detail

Intensive/Coronary Care Unit : Dartmouth General Hospital

https://libcat.nshealth.ca/en/permalink/chpams34987
Nova Scotia Health Authority. Dartmouth General Hospital. ICU, Nova Scotia Health Authority. Dartmouth General Hospital. CCU. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0685
Available Online
View Pamphlet
The Intensive/Coronary Care Unit is an intensive care and coronary care unit at Dartmouth General Hospital. This pamphlet outlines what to expect when your family member is admitted to the I/CCU. Topics include having a family spokesperson, visiting, infection risks, and the members of the health care team. What will happen when your family member leaves the unit, taking care of yourself, and frequently asked questions are explained. Space for journaling is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Dartmouth General Hospital. ICU
Nova Scotia Health Authority. Dartmouth General Hospital. CCU
Alternate Title
Intensive Care Unit/Coronary Care Unit : Dartmouth General Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Intensive care units
Coronary care units
Subjects (LCSH)
Intensive care units
Coronary care units
Specialty
Dartmouth General Hospital
Abstract
The Intensive/Coronary Care Unit is an intensive care and coronary care unit at Dartmouth General Hospital. This pamphlet outlines what to expect when your family member is admitted to the I/CCU. Topics include having a family spokesperson, visiting, infection risks, and the members of the health care team. What will happen when your family member leaves the unit, taking care of yourself, and frequently asked questions are explained. Space for journaling is provided.
Notes
previous title: Welcome to the ICU/CCU at the Dartmouth General Hospital
Responsibility
Prepared by: I/CCU staff, Dartmouth General Hospital
Pamphlet Number
0685
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Lymph node dissection at the QEII

https://libcat.nshealth.ca/en/permalink/chpams35727
Nova Scotia Health Authority. QEII. Surgery Clinic. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1205
Available Online
View Pamphlet
This guide will help you and your family through your surgery experience. It will help you to learn about the care you will receive and how you can help yourself before and after surgery. Topics include: lymph nodes (what are they? what happens after they are removed?), getting ready for surgery, the day of surgery, after your surgery, exercises after surgery, getting out of bed for the first time, taking care of your incision and drainage tubes, exercises at home, and followup visits with your…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Surgery Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (21 p.) : digital, PDF file
Subjects (MeSH)
Lymph Node Excision
Subjects (LCSH)
Lymph nodes--Cancer
Specialty
Breast Disease
Abstract
This guide will help you and your family through your surgery experience. It will help you to learn about the care you will receive and how you can help yourself before and after surgery. Topics include: lymph nodes (what are they? what happens after they are removed?), getting ready for surgery, the day of surgery, after your surgery, exercises after surgery, getting out of bed for the first time, taking care of your incision and drainage tubes, exercises at home, and followup visits with your surgeon.
Responsibility
Prepared by: Surgery Clinic staff, QEII
Pamphlet Number
1205
Less detail

Managing your fluid intake in chronic kidney disease

https://libcat.nshealth.ca/en/permalink/chpams35545
Nova Scotia Health Authority. NSHA Renal Program. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
0538
Available Online
View Pamphlet
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease. The pamphlet includes signs that you are taking in too much fluid, guidelines for fluid intake, sources of fluid in the diet, and tips for controlling your fluid intake.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSHA Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Kidney Diseases - diet therapy
Subjects (LCSH)
Kidneys--Diseases--Nutritional aspects
Abstract
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease. The pamphlet includes signs that you are taking in too much fluid, guidelines for fluid intake, sources of fluid in the diet, and tips for controlling your fluid intake.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
0538
Less detail

Medical abortion

https://libcat.nshealth.ca/en/permalink/chpams35888
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1831
Available Online
View Pamphlet
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1831
Less detail

Medical abortion (Mifegymiso) instructions

https://libcat.nshealth.ca/en/permalink/chpams35935
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1878
Available Online
View Pamphlet
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1878
Less detail

Memory after acquired brain injury (ABI)

https://libcat.nshealth.ca/en/permalink/chpams36548
Nova Scotia Health Authority. Acquired Brain Injury Ambulatory Care Teams. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1986
Available Online
View Pamphlet
Memory has many parts. It includes taking in, storing, and recalling information. After an acquired brain injury (ABI), you may have changes in your memory. This is common. This pamphlet explains how memory changes might affect you, and tips for managing your memory. A resources section is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Acquired Brain Injury Ambulatory Care Teams
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Memory
Brain Injuries - psychology
Subjects (LCSH)
Memory
Brain--Wounds and injuries--Complications
Abstract
Memory has many parts. It includes taking in, storing, and recalling information. After an acquired brain injury (ABI), you may have changes in your memory. This is common. This pamphlet explains how memory changes might affect you, and tips for managing your memory. A resources section is included.
Responsibility
Prepared by: Acquired Brain Injury Ambulatory Care Teams
Pamphlet Number
1986
Less detail

My heart failure passport

https://libcat.nshealth.ca/en/permalink/chpams38232
Nova Scotia Health Authority. QE II. Cardiology 6.2. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2373
Available Online
View Pamphlet
This Passport will help you take an active part in treating your heart failure. You can use it to record daily measurements (like your weight, blood pressure, heart rate, symptoms, and how you are feeling) and any medications you are taking. It can also help you to understand your disease better and learn about the importance of making changes to your lifestyle.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QE II. Cardiology 6.2
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Heart Failure
Subjects (LCSH)
Heart failure
Specialty
Cardiovascular System
Abstract
This Passport will help you take an active part in treating your heart failure. You can use it to record daily measurements (like your weight, blood pressure, heart rate, symptoms, and how you are feeling) and any medications you are taking. It can also help you to understand your disease better and learn about the importance of making changes to your lifestyle.
Responsibility
Prepared by: Cardiology 6.2, QE II
Pamphlet Number
2373
Less detail

Naltrexone for alcohol use disorder

https://libcat.nshealth.ca/en/permalink/chpams37555
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2263
Available Online
View Pamphlet
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much nalt…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Naltrexone
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Naltrexone
Alcoholism--Treatment
Specialty
Medications
Abstract
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much naltrexone costs.
Notes
Previous title: Naltrexone for alcohol dependence
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2263
Less detail

Neonatal abstinence syndrome

https://libcat.nshealth.ca/en/permalink/chpams36769
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2144
Available Online
View Pamphlet
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2144
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Outpatient withdrawal management

https://libcat.nshealth.ca/en/permalink/chpams37627
Nova Scotia Health Authority. Mental Health and Addictions Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2312
Available Online
View Pamphlet
This guide has helpful information for you and/or your support person(s) about the Outpatient Withdrawal Management Service and what you can expect during the withdrawal process. This pamphlet describes withdrawal and symptoms. It also explains the benefits and risks in taking part in the program. Common questions are answered such as how long the process will take, what you can do to manage symptoms, things to avoid during treatment, and what will happen after the process is over. Benefits of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Alcoholism - drug therapy
Subjects (LCSH)
Alcoholism--Treatment
Abstract
This guide has helpful information for you and/or your support person(s) about the Outpatient Withdrawal Management Service and what you can expect during the withdrawal process. This pamphlet describes withdrawal and symptoms. It also explains the benefits and risks in taking part in the program. Common questions are answered such as how long the process will take, what you can do to manage symptoms, things to avoid during treatment, and what will happen after the process is over. Benefits of having a support person(s) and how they can help are outlined. Information on who to call for support and how to give feedback on the program is also provided.
Responsibility
Prepared by: Outpatient Withdrawal Management Service, Mental Health and Addictions
Pamphlet Number
2312
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Prendre vos médicaments

https://libcat.nshealth.ca/en/permalink/chpams36479
Nova Scotia Health Authority. Mental Health and Addictions Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1916
Available Online
View Pamphlet
Prendre vos médicaments est une partie importante de votre traitement. Cela signifie que vous contribuez à votre santé et à votre bien-être. La présente brochure explique pourquoi certaines personnes cessent de prendre leurs médicaments. Si cela vous préoccupe ou si vous avez d’autres inquiétudes, veuillez en parler à vos prestataires de soins primaires, qui pourront vous aider à trouver des solutions. Des conseils sont présentés pour vous aider à prendre vos médicaments. ; This pamphlet is a F…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions Program
Alternate Title
Taking your medication
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Psychiatry
Medication
Subjects (LCSH)
Drugs
Mental health
Specialty
Mental Health
Abstract
Prendre vos médicaments est une partie importante de votre traitement. Cela signifie que vous contribuez à votre santé et à votre bien-être. La présente brochure explique pourquoi certaines personnes cessent de prendre leurs médicaments. Si cela vous préoccupe ou si vous avez d’autres inquiétudes, veuillez en parler à vos prestataires de soins primaires, qui pourront vous aider à trouver des solutions. Des conseils sont présentés pour vous aider à prendre vos médicaments.
This pamphlet is a French translation of "Taking Your Medication" pamphlet 0758. Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed.
Responsibility
Prepared by: Mental Health and Addictions Program
Pamphlet Number
1916
Less detail

Respiratory (breathing) infections

https://libcat.nshealth.ca/en/permalink/chpams35486
Nova Scotia Health Authority. Infection Prevention and Control. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1551
Available Online
View Pamphlet
This pamphlet explains the main differences between the common cold, the flu, and COVID-19. Information on symptoms and how these infections are spread is provided. How to protect yourself and others from getting respiratory infections, instructions for what to do if your symptoms get worse, and medicines available are listed. What to expect if you are admitted to the hospital for respiratory symptoms is also outlined. Your essential care partners and visitors will be asked to follow the same s…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Infection Prevention and Control
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Common Cold - prevention & control
Influenza, Human - prevention & control
COVID-19
Subjects (LCSH)
Cold (Disease)
Influenza
COVID-19 (Disease)
Abstract
This pamphlet explains the main differences between the common cold, the flu, and COVID-19. Information on symptoms and how these infections are spread is provided. How to protect yourself and others from getting respiratory infections, instructions for what to do if your symptoms get worse, and medicines available are listed. What to expect if you are admitted to the hospital for respiratory symptoms is also outlined. Your essential care partners and visitors will be asked to follow the same safety Infection Prevention and Control (IPAC) measures when giving you direct care in the hospital. The French version of this pamphlet 1552, "Infections respiratoires," is also available.
Notes
Previous title: Cold & flu season : taking care while you're in the hospital
Responsibility
Prepared by: Infection Prevention and Control
Pamphlet Number
1551
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

56 records – page 2 of 3.